Transaction concludes with the launch of “Awakn Clinics Oslo AS” as part of Awakn Life Sciences Nordic Expansion  TORONTO, October 05, 2021 – Awakn Life Sciences Corp. (“Awakn” or the “Company”),…

This was the world’s first published study assessing MDMA-assisted psychotherapy as a treatment for addiction TORONTO, September 23, 2021 – Awakn Life Sciences Corp. (Awakn), (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) a…

Launches Nordics Regional Expansion Dr. Lowan Stewart, One of Europe’s Preeminent Ketamine Physicians, Appointed as Awakn’s Regional Director for the Nordics TORONTO, September ##, 2021 – Awakn Life Sciences Corp. (“Awakn”…

TORONTO, CANADA, 15 SEPTEMBER 2021 – Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a biotechnology company with clinical operations developing and delivering psychedelic medicines to better…

TORONTO, CANADA, 02 SEPTEMBER 2021 – Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a biotechnology company developing and delivering psychedelic medicines to treat Addiction, announces that…

Recruitment Has Commenced for the First-Of-Its-Kind, U.K. – based Study, Led by Renowned Ketamine Researcher Toronto, Ontario–(Newsfile Corp. – August 24, 2021) – Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB:…

Toronto, Ontario–(Newsfile Corp. – August 12, 2021) – Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (‘Awakn’), a biotechnology company with clinical operations developing and delivering psychedelic medicines to better…

Toronto, Ontario–(Newsfile Corp. – August 9, 2021) – Awakn Life Sciences Corp. (NEO: AWKN) (OTC Pink: AWKNF) (‘Awakn’), a biotechnology company with clinical operations developing and delivering psychedelic medicines to…

The clinic will deliver psychedelic-assisted psychotherapy treatments for Addiction and other mental health conditions and is scheduled to open during the fourth quarter of 2021. Awakn Clinics London will join…

Toronto, Ontario–(Newsfile Corp. – July 26, 2021) – Awakn Life Sciences Corp. (NEO: AWKN) (OTC Pink: AWKNF) (‘Awakn’), a biotechnology company with clinical operations developing and delivering psychedelic medicines to…

TORONTO, CANADA, 22 JULY 2021 – Awakn Life Sciences Corp. (NEO: AWKN) (Awakn), a biotechnology company with clinical operations developing and delivering medicines to better treat Addiction, is delighted to…

Program to focus on developing and delivering new treatments for substance and behavioral addictions. TORONTO, CANADA, 14 JULY 2021 – Awakn Life Sciences Corp. (NEO: AWKN) (Awakn), a biotechnology company…